Evidence map›Paper›PMID 31001765›Full record

ArticleMolecular imaging and biology2020

The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional Radionuclides.

L M Carter, Adam Leon Kesner, E C Pratt, V A Sanders, A V F Massicano, C S Cutler, S E Lapi, Jason S Lewis

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Molecular imaging and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 84 citations in OpenAlex.

  1. Functional pituitary adenoma imaging.Reviews in endocrine & metabolic disorders · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Multiplexed imaging of radionuclides.Nature biomedical engineering · 2025
    Review
  9. Impact of tissue-independent positron range correction on [European journal of nuclear medicine and molecular imaging · 2025
    Article
  10. Review
  11. Article
  12. Examination of the PET in vivo generatorEuropean journal of nuclear medicine and molecular imaging · 2024
    Article
  13. Clinical use of [Pituitary · 2024
    Article
  14. Development ofMolecular imaging and biology · 2024
    Article
  15. Article
  16. Article
  17. Exploring the PET in vivo generatorbioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Article
  20. 2-deoxy-2-[Molecular imaging and biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

L M CarterDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-4848-4190
Adam Leon KesnerDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kesnera@mskcc.org.
E C PrattDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
V A SandersCollider-Accelerator Department, Brookhaven National Laboratory, Upton, NY, USA.
A V F MassicanoDepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.
C S CutlerCollider-Accelerator Department, Brookhaven National Laboratory, Upton, NY, USA.
S E LapiDepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Jason S LewisDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. lewisj2@mskcc.org.
Memorial Sloan Kettering Cancer Center · USBrookhaven National Laboratory · USUniversity of Alabama at Birmingham · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Development of a Novel Peptide Platform for Targeted PET Imaging and Radiotherapy of Breast CancerF32EB025050 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI CARTER, LUKAS MICHAEL · 2017 to 2019
$179k
NCI NIH HHS P30 CA008748NIBIB NIH HHS F32 EB025050
6 · The paper itself

Abstract

purposeThe increasing interest and availability of non-standard positron-emitting radionuclides has heightened the relevance of radionuclide choice in the development and optimization of new positron emission tomography (PET) imaging procedures, both in preclinical research and clinical practice. Differences in achievable resolution arising from positron range can largely influence application suitability of each radionuclide, especially in small-ring preclinical PET where system blurring factors due to annihilation photon acollinearity and detector geometry are less significant. Some resolution degradation can be mitigated with appropriate range corrections implemented during image reconstruction, the quality of which is contingent on an accurate characterization of positron range. PROCEDURES: To address this need, we have characterized the positron range of several standard and non-standard PET radionuclides (As-72, F-18, Ga-68, Mn-52, Y-86, and Zr-89) through imaging of small-animal quality control phantoms on a benchmark preclinical PET scanner. Further, the Particle and Heavy Ion Transport code System (PHITS v3.02) code was utilized for Monte Carlo modeling of positron range-dependent blurring effects.

resultsPositron range kernels for each radionuclide were derived from simulation of point sources in ICRP reference tissues. PET resolution and quantitative accuracy afforded by various radionuclides in practicable imaging scenarios were characterized using a convolution-based method based on positron annihilation distributions obtained from PHITS. Our imaging and simulation results demonstrate the degradation of small animal PET resolution, and quantitative accuracy correlates with increasing positron energy; however, for a specific "benchmark" preclinical PET scanner and reconstruction workflow, these differences were observed to be minimal given radionuclides with average positron energies below ~ 400 keV.

conclusionOur measurements and simulations of the influence of positron range on PET resolution compare well with previous efforts documented in the literature and provide new data for several radionuclides in increasing clinical and preclinical use. The results will support current and future improvements in methods for positron range corrections in PET imaging.

Indexed as

Monte Carlo MethodPhantoms, ImagingAnimalsComputer SimulationDiagnostic ImagingGallium RadioisotopesImage Processing, Computer-AssistedManganeseMicePositron-Emission TomographyRadioisotopesRadiopharmaceuticalsZirconiumGallium-68Gallium RadioisotopesManganeseManganese-52RadioisotopesRadiopharmaceuticalsZirconiumZirconium-89Monte Carlo simulationPETPhantomPHITSPoint spread functionPositron rangeSpatial resolution

Identifiers

PMID31001765
PMCPMC6805144
OpenAlexW2936847097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.